Evidence map›Paper›PMID 40995262›Full record

ArticleCureus2025

Idiopathic Eruptive Cherry Angiomatosis: A Case Series of Three Healthy Women.

Adriana Campo, Travis Frantz, Monica L Borza, David S Kirwin, Willis H Lyford

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adriana CampoDepartment of Dermatology, Naval Medical Center San Diego, San Diego, USA.
Travis FrantzDepartment of Dermatology, Naval Medical Center San Diego, San Diego, USA.
Monica L BorzaDepartment of Dermatology, Naval Medical Center San Diego, San Diego, USA.
David S KirwinDepartment of Dermatology, Naval Medical Center San Diego, San Diego, USA.
Willis H LyfordDepartment of Dermatology, Naval Medical Center San Diego, San Diego, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eruptive cherry angiomatosis (eCA) is a rare clinical diagnosis. The underlying pathophysiology is unknown, but eCA has been associated with medications, lymphoproliferative disease, graft versus host disease, immunosuppression, and human herpesvirus-8. To our knowledge, there have not been previous reports of eCA in healthy female patients. The goal of this case report is to describe the clinical characteristics and present a novel case series of three otherwise healthy adult women and attempt to characterize common features, comparing patient demographics, any associated comorbidities, clinical presentation, and treatment. Three female patients (aged 52, 42, and 38 years) from Southern California were diagnosed with eCA. All three patients were experiencing hormonal fluctuations at the time of onset, including perimenopause and pregnancy. Despite stabilization of their hormonal conditions, their lesions have persisted. Patient A has had her cherry angiomas treated several times with a 595 nm pulse dye laser; however, her lesions have continued to recur. The other two patients have not sought treatment. All patients are in good health without any significant comorbidities.

Indexed as

angiomadermatologyeruptive cherry angiomatosisfemale patientspatient counselingred bumpsskin growth

Identifiers

PMID40995262
PMCPMC12456670

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.